Sutro Biopharma, Inc.
Sutro Biopharma, Inc. (STRO) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
stro · stock forecast · 20 analysts (3M) · FMP · updated Jun 9, 2026
Analyst Rating & Consensus
Based on 20 Wall Street analysts in the past 3 months
Buy
20 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$60.00
Consensus
$51.80
+103.9% upside
Low
$43.00
Median: $50 · Last Close: $25.41
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Consensus Target
$51.80
103.9% upside
High Target
$60
136.1%
Low Target
$43
69.2%
Current Price
$25.41
as of today
Based on analyst price targets, the STRO stock price prediction for the next 12 months ranges from $43 to $60. The consensus STRO price forecast of $51.80 implies 103.9% upside from the current price of $25.41.
Short-Term Price Prediction
Algorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-10 | $24.14 | ↓ 5.00% |
1-day model range: $23.85–$24.43. Peak: $24.43 (-5.00%).
Long-Term Stock Price Prediction
Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $56 | +120.0% |
| 2028 | $89 | +252.0% |
| 2029 | $116 | +357.6% |
| 2030 | $134 | +426.2% |
| 2031 | — | +465.7% |
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
BEARISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · STRO · Jun 9, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-05-15 | Leerink Partners | Maintains | Outperform→Outperform |
| 2026-05-15 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-05-15 | Wedbush | Upgrade ↑ | Neutral→Outperform |
| 2026-04-23 | Citizens | Maintains | Market Outperform→Market Outperform |
| 2026-04-17 | Citizens | Maintains | Market Outperform→Market Outperform |
| 2026-03-25 | Deutsche Bank | Maintains | Buy→Buy |
| 2026-03-24 | Wells Fargo | Upgrade ↑ | Equal Weight→Overweight |
| 2026-03-24 | HC Wainwright & Co. | Upgrade ↑ | Neutral→Buy |
| 2026-01-20 | Citizens | Upgrade ↑ | Market Perform→Market Outperform |
| 2025-12-22 | HC Wainwright & Co. | Maintains | Neutral→Neutral |
Wall Street analysts have recently issued updated ratings on Sutro Biopharma, Inc. (STRO) stock. Of the recent 73 rating actions, 5 were upgrades and 4 were downgrades. 20 analysts currently cover STRO.
Analyst Recommendation Trends
STRO analyst recommendation trends show increasing buy-side sentiment over the past 6 months. Buy rating actions changed from 0 to 3 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$44M
↑ 33.4% YoY
Revenue Next Year
$35M
↓ 21.6% YoY
EPS This Year
$-8.72
EPS Next Year
$-7.53
↓ 13.7% YoY
EPS ForecastReported vs Estimated
Analysts forecast STRO EPS of $-8.72 for the current fiscal year, based on estimates from 7 analysts. The STRO revenue forecast is $44M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The STRO stock forecast is supported by two independent data sources: analyst consensus ratings from 20 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus STRO price target is $51.80 (+103.9% upside), with an analyst consensus of Buy.
The STRO short-term stock prediction for tomorrow is $24.14 (-5.00%). The STRO stock price prediction for 2027 estimates an average of $56. The STRO stock prediction for 2030 projects a range of $116–$151.
Sutro Biopharma, Inc. trades on NASDAQ under the ticker STRO. The STRO stock outlook for 2027 is broadly positive, supported by a Buy consensus among 90% of covering analysts.
Frequently asked questions
STRO forecast · 8 questionsAccording to 20 Wall Street analysts, the average 12-month STRO price target is $51.80, with a high forecast of $60.00 and a low of $43.00. The median price target is shown in the chart above when available. This implies +103.9% potential upside from the current price of $25.41.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.